Angiotensin II type 1 receptor blockade inhibits the development and progression of HIV-associated nephropathy in a mouse model

Journal of the American Society of Nephrology

Volumn 18, Issue 2, 2007, Pages 515-527

  Hiramatsu, Noriyuki ^a   Hiromura, Keiju ^a   Shigehara, Tetsuya ^a,b   Kuroiwa, Takashi ^a   Ideura, Hiroshi ^a   Sakurai, Noriyuki ^a   Takeuchi, Shigeru ^a   Tomioka, Mai ^a   Ikeuchi, Hidekazu ^a   Kaneko, Yoriaki ^a   Ueki, Kazue ^a   Kopp, Jeffrey B ^b   Nojima, Yoshihisa ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; AZELNIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; DOXYCYCLINE; KI 67 ANTIGEN; NEPHRIN; OLMESARTAN; PODOCIN; SYNAPTOPODIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; VPR PROTEIN; WILMS TUMOR 1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FOCAL GLOMERULOSCLEROSIS; GENE EXPRESSION; GLOMERULUS CAPILLARY; HEMINEPHRECTOMY; HIV ASSOCIATED NEPHROPATHY; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPERPLASIA; HYPERTROPHY; KIDNEY DISEASE; KIDNEY INJURY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEINURIA; RENAL PROTECTION; RENOVASCULAR HYPERTENSION; TRANSGENIC MOUSE; TREATMENT OUTCOME; VIRUS GENE; VPR GENE;

EID: 33846666637     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006030217     Document Type: Article

References (55)

1. D'Agati V, Appel GB: HIV infection and the kidney. J Am Soc Nephrol 8: 138-152, 1997
2. Ross MJ, Klotman PE: Recent progress in HIV-associated nephropathy. J Am Soc Nephrol 13: 2997-3004, 2002
3. Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE: Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol 16: 2412-2420, 2005
4. Kopp JB, Winkler C: HIV-associated nephropathy in African Americans. Kidney Int Suppl 83: S43-S49, 2003
5. Rao TK, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310: 669-673, 1984
6. D'Agati V, Appel GB: Renal pathology of human immunodeficiency virus infection. Semin Nephrol 18: 406-421, 1998
7. Barisoni L, Bruggeman LA, Mundel P, D'Agati VD, Klotman PE: HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 58: 173-181, 2000
8. Kriz W, LeHir M: Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 67: 404-419, 2005
9. Kimmel PL: HIV-associated nephropathy: Virologic issues related to renal sclerosis. Nephrol Dial Transplant 18[Suppl 6]: vi59-vi63, 2003
10. Green DF, Resnick L, Bourgoignie JJ: HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro. Kidney Int 41: 956-960, 1992
11. Alpers CE, McClure J, Bursten SL: Human mesangial cells are resistant to productive infection by multiple strains of human immunodeficiency virus types 1 and 2. Am J Kidney Dis 19: 126-130, 1992
12. Ray PE, Liu XH, Henry D, Dye L 3rd, Xu L, Orenstein JM, Schuztbank TE: Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy. Kidney Int 53: 1217-1229, 1998
13. Tokizawa S, Shimizu N, Hui-Yu L, Deyu F, Haraguchi Y, Oite T, Hoshino H: Infection of mesangial cells with HIV and SIV: Identification of GPR1 as a coreceptor. Kidney Int 58: 607-617, 2000
14. Cohen AH, Sun NC, Shapshak P, Imagawa DT: Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod Pathol 2: 125-128, 1989
15. Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, Burns GC, D'Agati VD, Winston JA, Klotman ME, Klotman PE: Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 11: 2079-2087, 2000
16. Marras D, Bruggeman LA, Gao F, Tanji N, Mansukhani MM, Cara A, Ross MD, Gusella GL, Benson G, D'Agati VD, Hahn BH, Klotman ME, Klotman PE: Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 8: 522-526, 2002
17. Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE: Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 100: 84-92, 1997
18. Lu TC, Ross M: HIV-associated nephropathy: A brief review. Mt Sinai J Med 72: 193-199, 2005
19. Zhong J, Zuo Y, Ma J, Fogo AB, Jolicoeur P, Ichikawa I, Matsusaka T: Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int 68: 1048-1060, 2005
20. Shigehara T, Zaragoza C, Kitiyakara C, Takahashi H, Lu H, Moeller M, Holzman LB, Kopp JB: Inducible podocyte-specific gene expression in transgenic mice. J Am Soc Nephrol 14: 1998-2003, 2003
21. Striker GE, Nagle RB, Kohnen PW, Smuckler EA: Response to unilateral nephrectomy in old rats. Arch Pathol 87: 439-442, 1969
22. Glasser RJ, Velosa JA, Michael AF: Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis. Lab Invest 36: 519-526, 1977
23. Steffes MW, Brown DM, Mauer SM: Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes 27: 35-41, 1978
24. Nagata M, Kriz W: Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int 42: 148-160, 1992
25. Wang W, Tzanidis A, Divjak M, Thomson NM, Stein-Oakley AN: Altered signaling and regulatory mechanisms of apoptosis in focal and segmental glomerulosclerosis. J Am Soc Nephrol 12: 1422-1433, 2001
26. Kusano H, Muso E, Ono T, Nogaki F, Nomura K, Takeda T, Miyawaki S, Matsumori A, Yoshida H, Sasayama S: Heminephrectomy causes the progression of glomerulosclerosis and apoptosis in high IgA strain ddY mice. Nephron 92: 389-398, 2002
27. Onogi H, Inagi R, Nangaku M, Ueda Y, Miyata T, Kurokawa K: Accelerated glomerular injury in hemi-nephrectomized transgenic mice of mesangial cell-predominant serpin, megsin. Nephron Exp Nephrol 96: e127-e133, 2004
28. Giatras I, Lau J, Levey AS: Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: A meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. Ann Intern Med 127: 337-345, 1997
29. Lavoie JL, Bianco RA, Sakai K, Keen HL, Ryan MJ, Sigmund CD: Transgenic mice for studies of the renin-angiotensin system in hypertension. Acta Physiol Scand 181: 571-577, 2004
30. Brewster UC, Perazella MA: The renin-angiotensin-aldosterone system and the kidney: Effects on kidney disease. Am J Med 116: 263-272, 2004
31. Remuzzi G, Perico N, Macia M, Ruggenenti P: The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl 99: S57-S65, 2005
32. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K: Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephroric syndrome. Mol Cell 1: 575-582, 1998
33. Endlich K, Kriz W, Witzgall R: Update in podocyte biology. Curr Opin Nephrol Hypertens 10: 331-340, 2001
34. Pavenstadt H, Kriz W, Kretzler M: Cell biology of the glomerular podocyte. Physiol Rev 83: 253-307, 2003
35. Wolf G, Chen S, Ziyadeh FN: From the periphery of the glomerular capillary wall toward the center of disease: Podocyte injury comes of age in diabetic nephropathy. Diabetes 54: 1626-1634, 2005
36. Matsusaka T, Xin J, Niwa S, Kobayashi K, Akatsuka A, Hashizume H, Wang QC, Pastan I, Fogo AB, Ichikawa I: Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol 16: 1013-1023, 2005
37. Barisoni L, Mokrzycki M, Sablay L, Nagata M, Yamase H, Mundel P: Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int 58: 137-143, 2000
38. Barisoni L, Kriz W, Mundel P, D'Agati V: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10: 51-61, 1999
39. Yang Y, Gubler MC, Beaufils H: Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy. Nephron 91: 416-423, 2002
40. Jowett JB, Planelles V, Poon B, Shah NP, Chen ML, Chen IS: The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J Virol 69: 6304-6313, 1995
41. Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HL, Zamzami N, Costantini P, Druillennec S, Hoebeke J, Briand JP, Irinopoulou T, Daugas E, Susin SA, Cointe D, Xie ZH, Reed JC, Roques BP, Kroemer G: The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med 191: 33-46, 2000
42. Muthumani K, Kudchodkar S, Papasavvas E, Montaner LJ, Weiner DB, Ayyavoo V: HIV-1 Vpr regulates expression of beta chemokines in human primary lymphocytes and macrophages. J Leukoc Biol 68: 366-372, 2000
43. Mirani M, Elenkov I, Volpi S, Hiroi N, Chrousos GP, Kino T: HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: Potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection. J Immunol 169: 6361-6368, 2002
44. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, Fields TA, Svetkey LP, Flanagan KH, Klotman PE, Winston JA: The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 66: 1145-1152, 2004
45. Kimmel PL, Mishkin GJ, Umana WO: Captopril and renal survival in patients with human immunodeficiency virus nephropathy. Am J Kidney Dis 28: 202-208, 1996
46. Wei A, Burns GC, Williams BA, Mohammed NB, Visintainer P, Sivak SL: Long-term renal survival in HIV-associated nephropathy with angiotensin- converting enzyme inhibition. Kidney Int 64: 1462-1471, 2003
47. Mezzano SA, Ruiz-Ortega M, Egido J: Angiotensin II and renal fibrosis. Hypertension 38: 635-638, 2001
48. Shankland SJ, Ly H, Thai K, Scholey JW: Increased glomerular capillary pressure alters glomerular cytokine expression. Circ Res 75: 844-853, 1994
49. Brenner BM: Remission of renal disease: Recounting the challenge, acquiring the goal. J Clin Invest 110: 1753-1758, 2002
50. Gloy J, Henger A, Fischer KG, Nitschke R, Mundel P, Bleich M, Schollmeyer P, Greger R, Pavenstadt H: Angiotensin II depolarizes podocytes in the intact glomerulus of the rat. J Clin Invest 99: 2772-2781, 1997
51. Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, Deferrari G, Camussi G: Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 52: 1023-1030, 2003
52. Brinkkoetter PT, Holtgrefe S, van der Woude FJ, Yard BA: Angiotensin II type 1-receptor mediated changes in heparan sulfate proteoglycans in human SV40 transformed podocytes. J Am Soc Nephrol 15: 33-40, 2004
53. Chen S, Lee JS, Iglesias-de la Cruz MC, Wang A, Izquierdo-Lahuerta A, Gandhi NK, Danesh FR, Wolf G, Ziyadeh FN: Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: Implications for diabetic glomerulopathy. Nephrol Dial Transplant 20: 1320-1328, 2005
54. Hoffmann S, Podlich D, Hahnel B, Kriz W, Gretz N: Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 15: 1475-1487, 2004
55. Durvasula RV, Petermann AT, Hiromura K, Blonski M, Pippin J, Mundel P, Pichler R, Griffin S, Couser WG, Shankland SJ: Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 65: 30-39, 2004